Home MedAlliance

MedAlliance

PRISTINE Study with SELUTION SLR Sirolimus Drug Eluting Balloon: First Two Patients Enrolled

The PRISTINE registry is a follow up to the encouraging results seen in the PRESTIGE clinical trial (Below The Knee, Chronic Limb Threatening Ischemia) at 6 months.

First Sirolimus DEB Patient Enrolled in Japanese SELUTION SLR™ Study

The SELUTION SLR™ Study involves up to 132 patients across a number of centres in Japan. Its objective is to assess the safety and efficacy of SELUTION SLR for the treatment of lesions of superficial femoral arteries and/or popliteal arteries.

MedAlliance Announces Enrollment of the 1st Patient In Its SELUTION SLR™ 014 DEB Study for the treatment of In-Stent Restenosis

The objectives of this prospective, randomized, single-blind multicenter study are to demonstrate the safety and efficacy o SELUTION SLR™ 014 DEB n the treatment of ISR with either drug-eluting or bare-metal stents. The study will support the submission for FDA approval.

SELUTION SLR Sirolimus Drug Eluting Balloon for Endovascular Applications Receives CE Approval: Award Supported by 2 Year Results from the SELUTION SLR First-in-Human Study Involving 50 Patients

This award was supported by two-year results from the SELUTION SLR First-in-Human study, involving 50 patients enrolled across four German centres.